Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-07T12:23:22.793Z Has data issue: false hasContentIssue false
  • English
  • Français

Human parvovirus B19 infection within a family and risk for pregnant women

Published online by Cambridge University Press:  15 May 2009

A. Azzi ,
M. Trotta ,
K. Zakrzewska ,
E. Balzer ,
P. G. Rogasi ,
A. Carocci  and
F. Leoncini
A. Azzi
Affiliation:
Institute of Microbiology, University of Florence, Viale Morgagni 48, 50134 Florence, Italy
M. Trotta
Affiliation:
Unit of Infectious Diseases, Careggi Hospital, Florence
K. Zakrzewska
Affiliation:
Institute of Microbiology, University of Florence, Viale Morgagni 48, 50134 Florence, Italy
E. Balzer
Affiliation:
Unit of Infectious Diseases, Careggi Hospital, Florence
P. G. Rogasi
Affiliation:
Unit of Infectious Diseases, Careggi Hospital, Florence
A. Carocci
Affiliation:
Unit of Infectious Diseases, Careggi Hospital, Florence
F. Leoncini
Affiliation:
Unit of Infectious Diseases, Careggi Hospital, Florence
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

During an outbreak of parvovirus B19 infection among four related families at least 70% of the household contacts, including a woman at the 33rd week of pregnancy, became infected. Twins were born at the 39th week of pregnancy, both with B19 infection. B19 DNA was detected in their sera by a nested PCR, anti-B19 IgM was detectable only by an immunofluorescence assay, and low levels of maternal anti-B19 IgG were demonstrable by an immunoenzymatic test in the serum of both children. All the haematological parameters were normal at birth and 6 months later, when B19 DNA and anti-B19 antibody were no longer detectable in serum samples. This observation emphasizes the high risk of B19 infection among household contacts and the possibility of a favourable outcome of the foetal infection, possibly related to infection late in the pregnancy.

Type
Short Paper
Information
Epidemiology & Infection , Volume 117 , Issue 2 , October 1996 , pp. 401 - 403
Copyright
Copyright © Cambridge University Press 1996

References

1.Cohen, BJ, Buckley, MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151–3.CrossRefGoogle ScholarPubMed
2.Anderson, LJ.Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6: 711–8.CrossRefGoogle ScholarPubMed
3.Anderson, MJ. Higgins, PG. Davis, LR, et al. Experimental parvovirus infection in humans. J Infect Dis 1985; 152: 257–65.CrossRefGoogle ScholarPubMed
4.Bartolomei Corsi, O, Azzi, A, Morfini, M, Fanci, R, Rossi Ferrini, P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165–70.CrossRefGoogle ScholarPubMed
5.Anand, A, Gray, ES, Brown, T, Clewley, JP, Cohen, BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987; 316: 183–6.CrossRefGoogle ScholarPubMed
6.Anderson, LJ, Gillespie, SM, Torok, TJ, Hurwitz, ES, Tsou, CJ, Gary, GW. Risk of B19 infection following exposures to human parvovirus. Behring Inst Mitt 1990; 85: 60–3.Google Scholar
7.Bell, LM, Naides, SJ, Stoffman, P, Hodinka, RL, Plotkin, SA. Human parvovirus infection among hospital staff members after contact with infected patients. N Engl J Med 1989; 321: 485–91.CrossRefGoogle ScholarPubMed
8.Public Health Laboratory Service Working Party on Fifth Disease Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990; 300: 1166–70.CrossRefGoogle Scholar
9.Schwarz, TF, Nerlich, A, Roggendorf, M. Parvovirus B19 infection in pregnancy. Berhing Inst Mitt 1990; 85: 69–73.Google Scholar
10.Brown, KE, Spencer, WG, de Mayolo, J Antunez, et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895–6.CrossRefGoogle ScholarPubMed
11.Pattison, JR. Human parvovirus B19. BMJ 1994; 308: 149–50.CrossRefGoogle ScholarPubMed
12.Zakrzewska, K, Azzi, A, Patou, G, Morfini, M, Rafanelli, D, Pattison, JR. Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992; 81: 407–12.CrossRefGoogle ScholarPubMed
13.Azzi, A, Macchia, PA, Favre, C, Nardi, M, Zakrzewska, K, Bartolomei-Corsi, O. Aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia. Haematologica 1989; 74: 191–4.Google Scholar
14.Kurtzman, GJ, Ozawa, K, Cohen, B, Hanson, G, Oseas, R, Young, NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287–94.CrossRefGoogle ScholarPubMed
15.Koch, WC, Adler, SP, Harger, J. Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr J Infect Dis 1993; 12: 747–50.CrossRefGoogle ScholarPubMed